PartsTable
Technical Data Sheet
Download PDF

NOVOLIN-L — INSULIN HUMAN ZINC SUSPENSION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NOVOLIN-L: INSULIN HUMAN ZINC SUSPENSION.

The INSULIN HUMAN ZINC SUSPENSION is a the manufacturer industrial component. Key specifications include special_features: RECOMBINANT DNA ORIGIN (YEAST), primary_container_type: VIAL, MULTIPLE DOSE, therapeutic_equivalent: NOVOLIN BY NOVO NORDISK, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 10.000 MILLILITERS, active_medicament_medicinal_strength: 100.000 USP UNITS INSULIN PER MILLILITER. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-190-3582, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NOVOLIN-L
NSN: 6505-01-190-3582
FSC: 6505 — Drugs and Biologicals
CAGE: 60554 — NOVO NORDISK INC (USA)
SPECIFICATIONS
special_featuresRECOMBINANT DNA ORIGIN (YEAST)
primary_container_typeVIAL, MULTIPLE DOSE
therapeutic_equivalentNOVOLIN BY NOVO NORDISK
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
primary_container_content_quantity10.000 MILLILITERS
active_medicament_medicinal_strength100.000 USP UNITS INSULIN PER MILLILITER
part_name_assigned_by_controlling_agencyINSULIN HUMAN ZINC SUSPENSION USP 100UN/ML 10ML MULTI DOSE VIAL
NSN6505-01-190-3582
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available INSULIN HUMAN ZINC SUSPENSION TITLE COMPONENT PN NOVOLIN-L MFR INSULIN HUMAN ZINC SUS
KEY FEATURES
•
THERAPEUTIC EQUIVALENT: NOVOLIN BY NOVO NORDISK
•
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 USP UNITS INSULIN PER MILLILITER
TECHNICAL CHARACTERISTICS
THERAPEUTIC EQUIVALENTNOVOLIN BY NOVO NORDISK
PRIMARY CONTAINER CONTENT QUANTITY10.000 MILLILITERS
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPEVIAL, MULTIPLE DOSE
SPECIAL FEATURESRECOMBINANT DNA ORIGIN (YEAST)
PART NAME ASSIGNED BY CONTROLLING AGENCYINSULIN HUMAN ZINC SUSPENSION USP 100UN/ML 10ML MULTI DOSE VIAL
ACTIVE MEDICAMENT MEDICINAL STRENGTH100.000 USP UNITS INSULIN PER MILLILITER
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347
SUBSTITUTES & CROSS-REFERENCES 1
NDC00003-1835-10Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
No demilitarization required
Ready to buy NOVOLIN-L?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NOVOLIN-L?
NOVOLIN-L is a INSULIN HUMAN ZINC SUSPENSION.
What parts can replace NOVOLIN-L?
There is 1 known substitute for NOVOLIN-L: NDC00003-1835-10. Substitute compatibility should be verified for your specific system.
What is the NSN for NOVOLIN-L?
NOVOLIN-L is cataloged in the U.S. Government catalog under NSN 6505-01-190-3582. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NOVOLIN-L